08:00 , Jan 18, 2016 |  BC Week In Review  |  Company News

BioNanoSim, Immune Pharmaceuticals deal

BioNanoSim granted Immune Pharmaceuticals exclusive worldwide rights to develop and commercialize a topical nano-capsule formulation of cyclosporine to treat psoriasis and atopic dermatitis. In preclinical animal and human skin models, the new formulation delivered therapeutic...